{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:58:06Z","timestamp":1772895486704,"version":"3.50.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1187,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Cyclin G1 deficiency is associated with reduced incidence of carcinogen-induced hepatocellular carcinoma (HCC), but its function in HCC progression remains obscure. We report a critical role of cyclin G1 in HCC metastasis. Elevated expression of cyclin G1 was detected in HCCs (60.6%), and its expression levels were even higher in portal vein tumor thrombus. Clinicopathological analysis revealed a close correlation of cyclin G1 expression with distant metastasis and poor prognosis of HCC. Forced expression of cyclin G1 promoted epithelial-mesenchymal transition (EMT) and metastasis of HCC cells<\/jats:bold>\n                                 <jats:bold>\n                                    in vitro\n                                 <\/jats:bold>\n                                 <jats:bold>and<\/jats:bold>\n                                 <jats:bold>\n                                    in vivo\n                                 <\/jats:bold>. <jats:bold>Cyclin G1 overexpression enhanced Akt activation through interaction with p85 (regulatory subunit of phosphoinositide 3-kinase [PI3K]), which led to subsequent phosphorylation of glycogen synthase kinase-3\u03b2 (GSK-3\u03b2) and stabilization of Snail, a critical EMT mediator. These results suggest that elevated cyclin G1 facilitates HCC metastasis by promoting EMT via PI3K\/Akt\/GSK-3\u03b2\/Snail-dependent pathway. Consistently, we have observed a significant correlation between cyclin G1 expression and p-Akt levels in a cohort of HCC patients, and found that combination of these two parameters is a more powerful predictor of poor prognosis.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>Cyclin G1 plays a pivotal role in HCC metastasis and may serve as a novel prognostic biomarker and therapeutic target.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.25596","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T11:43:05Z","timestamp":1327318985000},"page":"1787-1798","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":84,"title":["Cyclin G1\u2013mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase\/Akt signaling facilitates liver cancer progression"],"prefix":"10.1097","volume":"55","author":[{"given":"Wen","family":"Wen","sequence":"first","affiliation":[]},{"given":"Jin","family":"Ding","sequence":"additional","affiliation":[]},{"given":"Wen","family":"Sun","sequence":"additional","affiliation":[]},{"given":"Jing","family":"Fu","sequence":"additional","affiliation":[]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Kun","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Beifang","family":"Ning","sequence":"additional","affiliation":[]},{"given":"Tao","family":"Han","sequence":"additional","affiliation":[]},{"given":"Lei","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[]},{"given":"Dong","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[]},{"given":"Gensheng","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Mengchao","family":"Wu","sequence":"additional","affiliation":[]},{"given":"Weifen","family":"Xie","sequence":"additional","affiliation":[]},{"given":"Hongyang","family":"Wang","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-17-20241201","first-page":"2113","article-title":"Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1.","volume":"8","author":"Tamura","year":"1993","journal-title":"Oncogene"},{"key":"R2-17-20241201","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/sj.onc.1206306","article-title":"Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation.","volume":"22","author":"Ohtsuka","year":"2003","journal-title":"Oncogene"},{"key":"R3-17-20241201","first-page":"2361","article-title":"Identification of p53 target genes through immune selection of genomic DNA: the cyclin G gene contains two distinct p53 binding sites.","volume":"10","author":"Zauberman","year":"1995","journal-title":"Oncogene"},{"key":"R4-17-20241201","doi-asserted-by":"crossref","first-page":"3290","DOI":"10.1038\/sj.onc.1204270","article-title":"Cyclin G1 is involved in G2M arrest in response to DNA damage and in growth control after damage recovery.","volume":"20","author":"Kimura","year":"2001","journal-title":"Oncogene"},{"key":"R6-17-20241201","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1097-2765(02)00504-X","article-title":"Cyclin G recruits PP2A to dephosphorylate Mdm2.","volume":"9","author":"Okamoto","year":"2002","journal-title":"Mol Cell"},{"key":"R7-17-20241201","doi-asserted-by":"crossref","first-page":"27449","DOI":"10.1074\/jbc.M111693200","article-title":"Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B subunits in active complexes and induces nuclear aberrations and a G1S phase cell cycle arrest.","volume":"277","author":"Bennin","year":"2002","journal-title":"J Biol Chem"},{"key":"R8-17-20241201","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-5793(96)01484-6","article-title":"GAK: a cyclin G associated kinase contains a tensinauxilinlike domain.","volume":"402","author":"Kanaoka","year":"1997","journal-title":"FEBS Lett"},{"key":"R9-17-20241201","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1067\/mob.2003.140","article-title":"Increased expression of cyclin G1 in leiomyoma compared with normal myometrium.","volume":"188","author":"Baek","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R10-17-20241201","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1007\/s11605-003-0034-8","article-title":"A better cell cycle target for gene therapy of colorectal cancer: cyclin G.","volume":"7","author":"Perez","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"R11-17-20241201","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1074\/jbc.274.16.11022","article-title":"Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53 cells.","volume":"274","author":"Reimer","year":"1999","journal-title":"J Biol Chem"},{"key":"R12-17-20241201","first-page":"3343","article-title":"Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrixtargeted retroviral vectors bearing a cytocidal cyclin G1 construct.","volume":"60","author":"Gordon","year":"2000","journal-title":"Cancer Res"},{"key":"R13-17-20241201","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/hum.1997.8.14-1667","article-title":"Retroviral vectormediated transfer of an antisense cyclin G1 construct inhibits osteosarcoma tumor growth in nude mice.","volume":"8","author":"Chen","year":"1997","journal-title":"Hum Gene Ther"},{"key":"R14-17-20241201","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/hep.510280235","article-title":"Regulation of cyclin G1 during murine hepatic regeneration following Dipininduced DNA damage.","volume":"28","author":"Jensen","year":"1998","journal-title":"HEPATOLOGY"},{"key":"R15-17-20241201","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1053\/jhep.2003.50137","article-title":"Reduced hepatic tumor incidence in cyclin G1deficient mice.","volume":"37","author":"Jensen","year":"2003","journal-title":"HEPATOLOGY"},{"key":"R16-17-20241201","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1083\/jcb.200601018","article-title":"The epithelialmesenchymal transition: new insights in signaling, development, and disease.","volume":"172","author":"Lee","year":"2006","journal-title":"J Cell Biol"},{"key":"R17-17-20241201","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2131","article-title":"Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?","volume":"7","author":"Peinado","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"R18-17-20241201","doi-asserted-by":"crossref","first-page":"27424","DOI":"10.1074\/jbc.M100827200","article-title":"A new role for E12E47 in the repression of Ecadherin expression and epithelialmesenchymal transitions.","volume":"276","author":"PerezMoreno","year":"2001","journal-title":"J Biol Chem"},{"key":"R19-17-20241201","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrm1175","article-title":"Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis.","volume":"4","author":"Grunert","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R20-17-20241201","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/nrd1580","article-title":"Development of TGFbeta signalling inhibitors for cancer therapy.","volume":"3","author":"Yingling","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"R21-17-20241201","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelialmesenchymal transition during tumor progression.","volume":"17","author":"Huber","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"R22-17-20241201","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1038\/sj.onc.1209091","article-title":"Epithelialmesenchymal transition in development and cancer: role of phosphatidylinositol 3 kinaseAKT pathways.","volume":"24","author":"Larue","year":"2005","journal-title":"Oncogene"},{"key":"R23-17-20241201","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/nature04872","article-title":"New signals from the invasive front.","volume":"441","author":"Christofori","year":"2006","journal-title":"Nature"},{"key":"R24-17-20241201","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.23221","article-title":"Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.","volume":"50","author":"Yang","year":"2009","journal-title":"HEPATOLOGY"},{"key":"R25-17-20241201","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1386-6346(02)00027-X","article-title":"Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases.","volume":"24","author":"Giannelli","year":"2002","journal-title":"Hepatol Res"},{"key":"R26-17-20241201","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1172\/JCI39374","article-title":"The polycomb group protein Bmi1 represses the tumor suppressor PTEN and induces epithelialmesenchymal transition in human nasopharyngeal epithelial cells.","volume":"119","author":"Song","year":"2009","journal-title":"J Clin Invest"},{"key":"R27-17-20241201","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer.","volume":"24","author":"Altomare","year":"2005","journal-title":"Oncogene"},{"key":"R28-17-20241201","doi-asserted-by":"crossref","first-page":"36803","DOI":"10.1074\/jbc.M005912200","article-title":"Phosphatidylinositol 3kinase function is required for transforming growth factor betamediated epithelial to mesenchymal transition and cell migration.","volume":"275","author":"Bakin","year":"2000","journal-title":"J Biol Chem"},{"key":"R29-17-20241201","first-page":"2172","article-title":"The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines.","volume":"63","author":"Grille","year":"2003","journal-title":"Cancer Res"},{"key":"R30-17-20241201","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1158\/0008-5472.CAN-06-3598","article-title":"PRL3 downregulates PTEN expression and signals through PI3K to promote epithelialmesenchymal transition.","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"R31-17-20241201","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1101\/gad.1011002","article-title":"Deregulated G1cyclin expression induces genomic instability by preventing efficient preRC formation.","volume":"16","author":"Tanaka","year":"2002","journal-title":"Genes Dev"},{"key":"R32-17-20241201","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelialmesenchymal transitions in tumour progression.","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R33-17-20241201","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/35000025","article-title":"The transcription factor snail controls epithelialmesenchymal transitions by repressing Ecadherin expression.","volume":"2","author":"Cano","year":"2000","journal-title":"Nat Cell Biol"},{"key":"R34-17-20241201","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1158\/0008-5472.CAN-05-3850","article-title":"Exploring a new twist on tumor metastasis.","volume":"66","author":"Yang","year":"2006","journal-title":"Cancer Res"},{"key":"R35-17-20241201","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ncb1173","article-title":"Dual regulation of Snail by GSK3betamediated phosphorylation in control of epithelialmesenchymal transition.","volume":"6","author":"Zhou","year":"2004","journal-title":"Nat Cell Biol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.25596","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:01:57Z","timestamp":1733061717000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201206000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.25596","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}